In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...

Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...

The companies' new effort would bypass traditional middlemen to cut the drug's monthly cost from a list price of around $606 ...

Even with an 87% drop in Comirnaty sales, Pfizer achieved 14% operational growth in the second quarter, driven by its diversified portfolio, including key products like Eliquis and new oncology drugs.

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...

The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...